MustGrow Biologics sees massive growth in patent portfolio

March 13, 2023 at 12:19 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially.

Giasson tells Proactive its IP portfolio has grown from 23 to 84 total patents issued and pending over the last three years. In fact, 62 have been issued which is an increase from 18 issued patents three years ago.

Contact Details

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/mustgrow-biologics-sees-massive-growth-in-patent-portfolio-976974759

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	245.96	-2.46 (-0.99%)
AAPL	332.41	+1.07 (0.32%)
AMD	512.50	+8.30 (1.65%)
BAC	57.90	-1.62 (-2.72%)
GOOG	339.36	-2.07 (-0.61%)
META	673.31	+3.07 (0.46%)
MSFT	490.30	-6.82 (-1.37%)
NVDA	213.90	+1.73 (0.82%)
ORCL	143.16	+2.81 (2.00%)
TSLA	358.08	+1.50 (0.42%)

Symbol

Price

Change (%)

AMZN

245.96

-2.46 (-0.99%)

AAPL

332.41

+1.07 (0.32%)

AMD

512.50

+8.30 (1.65%)

BAC

57.90

-1.62 (-2.72%)

GOOG

339.36

-2.07 (-0.61%)

MustGrow Biologics sees massive growth in patent portfolio

Contact Details

More News

Recent Quotes